Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1722870
PUBLISHER: IMARC | PRODUCT CODE: 1722870
Viral Vector Manufacturing Market Size, Share, Trends and Forecast by Type, Disease, Application, End User, and Region, 2025-2033
PUBLISHED:
PAGES: 146 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global viral vector manufacturing market size was valued at USD 1,469.6 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 8,512.2 Million by 2033, exhibiting a CAGR of 21.6% from 2025-2033. North America currently dominates the market, holding a market share of over 49.3% in 2024. The rising prevalence of genetic disorders, increasing adoption of gene therapies, advanced biotechnology infrastructure, expanding clinical trials, strong government funding, robust R&D investments, and the presence of leading pharmaceutical companies drive the viral vector manufacturing market in North America.
A viral vector is a tool used by molecular biologists for delivering genetic materials into cells. It is used to replace defective genes for curing genetic disorders and express and present pathogenic antigens for generating an immune response by mimicking a natural infection. It is widely employed in oncolytic therapies to target and kill tumor cells. Besides this, as it assists in treating different diseases, such as heart defects, metabolic diseases, and neurodegenerative disorders, it finds extensive applications in life science research, gene therapy and vaccinology. At present, there is a rise in viral vector manufacturing on account of the rising prevalence of genetic disorders due to a combination of gene mutations and damaged chromosomes in the body.
Viral Vector Manufacturing Market Trends:
The increasing cancer patients due to the rising alcohol consumption and sedentary lifestyles of individuals represents one of the key factors contributing to the growth of the market. In addition, there is a rise in the number of clinical studies undertaken on viral vectors across the globe. This, along with the growing utilization of viral vectors in novel drug delivery, is positively influencing the market. Besides this, they are efficient carriers of virus-disabling sequences and are used to deliver HIV-inhibiting transgenes to human hematopoietic stem cells (HSCs). Additionally, governments of several countries are launching campaigns to generate awareness about viral vector vaccines among individuals. They are also improving the regulatory environment via changes, such as fast-track approval processes. Furthermore, key market players are extensively investing in capacity expansion for manufacturing activities around the world. These players are also indulging in mergers and acquisitions (M&A), which is projected to increase their overall sales and profitability.
Key Market Segmentation:
Breakup by Type:
- Adenoviral Vectors
- Adeno-associated Viral Vectors
- Lentiviral Vectors
- Retroviral Vectors
- Others
Breakup by Disease:
- Cancer
- Genetic Disorders
- Infectious Diseases
- Others
Breakup by Application:
- Gene Therapy
- Vaccinology
Breakup by End User:
- Pharmaceutical and Biopharmaceutical Companies
- Research Institutes
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Cognate BioServices Inc. (Charles River Laboratories International Inc.), F. Hoffmann-La Roche AG, FinVector Oy, FUJIFILM Holdings Corporation, Kaneka Eurogentec S.A. (Kaneka Corporation), Lonza Group AG, Merck KGaA, Oxford Biomedica plc, REGENXBIO Inc., Sanofi S.A., Thermo Fisher Scientific Inc. and uniQure N.V.
Key Questions Answered in This Report
- 1.What is viral vector manufacturing?
- 2.How big is the global viral vector manufacturing market?
- 3.What is the expected growth rate of the global viral vector manufacturing market during 2025-2033?
- 4.What are the key factors driving the global viral vector manufacturing market?
- 5.What is the leading segment of the global viral vector manufacturing market based on type?
- 6.What is the leading segment of the global viral vector manufacturing market based on disease?
- 7.What is the leading segment of the global viral vector manufacturing market based on application?
- 8.What are the key regions in the global viral vector manufacturing market?
- 9.Who are the key players/companies in the global viral vector manufacturing market?
Product Code: SR112025A5016
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Viral Vector Manufacturing Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 Adenoviral Vectors
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Adeno-associated Viral Vectors
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Lentiviral Vectors
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Retroviral Vectors
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
7 Market Breakup by Disease
- 7.1 Cancer
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Genetic Disorders
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Infectious Diseases
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Application
- 8.1 Gene Therapy
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Vaccinology
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by End User
- 9.1 Pharmaceutical and Biopharmaceutical Companies
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Research Institutes
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Cognate BioServices Inc. (Charles River Laboratories International Inc.)
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.2 F. Hoffmann-La Roche AG
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.3 FinVector Oy
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.4 FUJIFILM Holdings Corporation
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 Kaneka Eurogentec S.A. (Kaneka Corporation)
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.6 Lonza Group AG
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.6.4 SWOT Analysis
- 15.3.7 Merck KGaA
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 Oxford Biomedica plc
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.8.4 SWOT Analysis
- 15.3.9 REGENXBIO Inc.
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 Sanofi S.A.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.11 Thermo Fisher Scientific Inc.
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.11.4 SWOT Analysis
- 15.3.12 uniQure N.V.
- 15.3.12.1 Company Overview
- 15.3.12.2 Product Portfolio
- 15.3.12.3 Financials
- 15.3.1 Cognate BioServices Inc. (Charles River Laboratories International Inc.)
Product Code: SR112025A5016
List of Figures
- Figure 1: Global: Viral Vector Manufacturing Market: Major Drivers and Challenges
- Figure 2: Global: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019-2024
- Figure 3: Global: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 4: Global: Viral Vector Manufacturing Market: Breakup by Type (in %), 2024
- Figure 5: Global: Viral Vector Manufacturing Market: Breakup by Disease (in %), 2024
- Figure 6: Global: Viral Vector Manufacturing Market: Breakup by Application (in %), 2024
- Figure 7: Global: Viral Vector Manufacturing Market: Breakup by End User (in %), 2024
- Figure 8: Global: Viral Vector Manufacturing Market: Breakup by Region (in %), 2024
- Figure 9: Global: Viral Vector Manufacturing (Adenoviral Vectors) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 10: Global: Viral Vector Manufacturing (Adenoviral Vectors) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 11: Global: Viral Vector Manufacturing (Adeno-associated Viral Vectors) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 12: Global: Viral Vector Manufacturing (Adeno-associated Viral Vectors) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 13: Global: Viral Vector Manufacturing (Lentiviral Vectors) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 14: Global: Viral Vector Manufacturing (Lentiviral Vectors) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 15: Global: Viral Vector Manufacturing (Retroviral Vectors) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 16: Global: Viral Vector Manufacturing (Retroviral Vectors) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 17: Global: Viral Vector Manufacturing (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 18: Global: Viral Vector Manufacturing (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 19: Global: Viral Vector Manufacturing (Cancer) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 20: Global: Viral Vector Manufacturing (Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 21: Global: Viral Vector Manufacturing (Genetic Disorders) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 22: Global: Viral Vector Manufacturing (Genetic Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 23: Global: Viral Vector Manufacturing (Infectious Diseases) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 24: Global: Viral Vector Manufacturing (Infectious Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 25: Global: Viral Vector Manufacturing (Other Diseases) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 26: Global: Viral Vector Manufacturing (Other Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 27: Global: Viral Vector Manufacturing (Gene Therapy) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 28: Global: Viral Vector Manufacturing (Gene Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 29: Global: Viral Vector Manufacturing (Vaccinology) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 30: Global: Viral Vector Manufacturing (Vaccinology) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 31: Global: Viral Vector Manufacturing (Pharmaceutical and Biopharmaceutical Companies) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 32: Global: Viral Vector Manufacturing (Pharmaceutical and Biopharmaceutical Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 33: Global: Viral Vector Manufacturing (Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 34: Global: Viral Vector Manufacturing (Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 35: North America: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 36: North America: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 37: United States: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 38: United States: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 39: Canada: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 40: Canada: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 41: Asia-Pacific: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 42: Asia-Pacific: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 43: China: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 44: China: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 45: Japan: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 46: Japan: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 47: India: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 48: India: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 49: South Korea: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 50: South Korea: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 51: Australia: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 52: Australia: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 53: Indonesia: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 54: Indonesia: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 55: Others: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 56: Others: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 57: Europe: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 58: Europe: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 59: Germany: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 60: Germany: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 61: France: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 62: France: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 63: United Kingdom: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 64: United Kingdom: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 65: Italy: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 66: Italy: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 67: Spain: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 68: Spain: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 69: Russia: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 70: Russia: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 71: Others: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 72: Others: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 73: Latin America: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 74: Latin America: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 75: Brazil: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 76: Brazil: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 77: Mexico: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 78: Mexico: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 79: Others: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 80: Others: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 81: Middle East and Africa: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 82: Middle East and Africa: Viral Vector Manufacturing Market: Breakup by Country (in %), 2024
- Figure 83: Middle East and Africa: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 84: Global: Viral Vector Manufacturing Industry: SWOT Analysis
- Figure 85: Global: Viral Vector Manufacturing Industry: Value Chain Analysis
- Figure 86: Global: Viral Vector Manufacturing Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Viral Vector Manufacturing Market: Key Industry Highlights, 2024 and 2033
- Table 2: Global: Viral Vector Manufacturing Market Forecast: Breakup by Type (in Million USD), 2025-2033
- Table 3: Global: Viral Vector Manufacturing Market Forecast: Breakup by Disease (in Million USD), 2025-2033
- Table 4: Global: Viral Vector Manufacturing Market Forecast: Breakup by Application (in Million USD), 2025-2033
- Table 5: Global: Viral Vector Manufacturing Market Forecast: Breakup by End User (in Million USD), 2025-2033
- Table 6: Global: Viral Vector Manufacturing Market Forecast: Breakup by Region (in Million USD), 2025-2033
- Table 7: Global: Viral Vector Manufacturing Market: Competitive Structure
- Table 8: Global: Viral Vector Manufacturing Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.